<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38019957</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2048-7207</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of the Pediatric Infectious Diseases Society</Title><ISOAbbreviation>J Pediatric Infect Dis Soc</ISOAbbreviation></Journal><ArticleTitle>Clinical Outcomes of Human Rhinovirus/Enterovirus Infection in Pediatric Hemopoietic Cell Transplant Patients.</ArticleTitle><Pagination><StartPage>75</StartPage><EndPage>83</EndPage><MedlinePgn>75-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jpids/piad106</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Respiratory viral infections are common among pediatric transplant patients, with human rhinovirus (HRV) being the most frequent. In pediatric patients undergoing hemopoietic cell transplant (HCT), infection with HRV has been associated with progression to lower respiratory tract infection (LRTI) and adverse outcomes. We describe the clinical presentation and outcomes of HRV infection in children undergoing HCT.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Single-center retrospective study. HCT recipients who were positive for HRV/EV (HRV+) or negative for any respiratory virus (VN) by BioFire® FilmArray® panel between October 2014 and December 2017, were included. Primary outcomes were progression to LRTI, ICU admission, all-cause mortality at 3 and 6 months, and respiratory event-related mortality at 6 months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">227 patients (160 allogeneic HCT) were included. Of all patients, 108/227 (47.6%) were HRV+. From all HRV+, 95/108 (88%) were symptomatic and 68/107 (63.6%) of the diagnosis were made pretransplant. The median age of HRV+ was significantly lower than VN patients (5 vs 10 years). Cough and rhinorrhea were more frequently observed in HRV+ (53.7 and 60% vs 19.8 and 22.8%, respectively). No differences were found between both groups pretransplant and overall in rates progression to LRTI, ICU admission, mechanical ventilation, all-cause within 3 and 6 months, and mortality related with respiratory failure. No significant association was found between the severity of respiratory disease and the type of conditioning, type of transplant, or absolute lymphocyte count.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">HRV infection is frequently detected in HCT recipients but is not associated with severity of respiratory disease, need for intensive care unit or mortality, including those diagnosed before transplant, suggesting that delaying HCT in this scenario may not be needed. Multicenter larger studies are required to confirm these findings.</AbstractText><CopyrightInformation>© The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Castejon-Ramirez</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8979-1819</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Tennessee Health Science Center College of Medicine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaisavaneeyakorn</LastName><ForeName>Sujittra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrolino</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allison</LastName><ForeName>Kim J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peterson</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallas</LastName><ForeName>Ronald H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suliman</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Transplant Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayden</LastName><ForeName>Randall T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maron</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Tennessee Health Science Center College of Medicine, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hijano</LastName><ForeName>Diego R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-2903-666X</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Tennessee Health Science Center College of Medicine, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>American</Agency><Country /></Grant><Grant><Agency>Lebanese Syrian Associated Charities</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Pediatric Infect Dis Soc</MedlineTA><NlmUniqueID>101586049</NlmUniqueID><ISSNLinking>2048-7193</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017690" MajorTopicYN="N">Cell Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">hemopoietic cell transplantation</Keyword><Keyword MajorTopicYN="N">human rhinovirus</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">respiratory viral infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>14</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38019957</ArticleId><ArticleId IdType="pmc">PMC10824257</ArticleId><ArticleId IdType="doi">10.1093/jpids/piad106</ArticleId><ArticleId IdType="pii">7455290</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jain S, Williams DJ, Arnold SR, et al. . Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med 2015; 372:835–45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4697461</ArticleId><ArticleId IdType="pubmed">25714161</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E, Ha K-S, Song DJ, Lee JH, Lee KC.. Clinical and laboratory profiles of hospitalized children with acute respiratory virus infection. Korean J Pediatr 2018; 61:180–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6021362</ArticleId><ArticleId IdType="pubmed">29963101</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltola V, Jartti T, Putto-Laurila A, et al. . Rhinovirus infections in children: a retrospective and prospective hospital-based study. J Med Virol 2009; 81:1831–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166645</ArticleId><ArticleId IdType="pubmed">19697407</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwane MK, Prill MM, Lu X, et al. . Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis 2011; 204:1702–10.</Citation><ArticleIdList><ArticleId IdType="pubmed">22013207</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen-Thi-Dieu T, Le-Thi-Thu H, Le-Thi-Minh H, Pham-Nhat A, Duong-Quy S.. Study of clinical characteristics and cytokine profiles of asthmatic children with rhinovirus infection during acute asthma exacerbation at National Hospital of Pediatrics. Can Respir J 2018; 2018:9375967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6126093</ArticleId><ArticleId IdType="pubmed">30210646</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson PE, Gilroy NM, Faux CE, et al. . Human rhinovirus C in adult haematopoietic stem cell transplant recipients with respiratory illness. J Clin Virol: Off Publ Pan Am Soc Clin Virol 2013; 56:255–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172717</ArticleId><ArticleId IdType="pubmed">23290385</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher BT, Danziger-Isakov L, Sweet LR, et al. . A Multicenter Consortium to Define the Epidemiology and Outcomes of Inpatient Respiratory Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients. J Pediatric Infect Dis Soc 2018; 7:275–82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107490</ArticleId><ArticleId IdType="pubmed">29106589</ArticleId></ArticleIdList></Reference><Reference><Citation>Canducci F, Debiaggi M, Ceresola ER, et al. . Infection and coinfection of human rhinovirus C in stem cell transplant recipients. Clin Develop Immunol 2013; 2013:236081. doi:10.1155/2013/236081</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/236081</ArticleId><ArticleId IdType="pmc">PMC3600225</ArticleId><ArticleId IdType="pubmed">23533453</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S, Waghmare A, Scott EM, et al. . Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality. Haematologica 2017; 102:1120–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451345</ArticleId><ArticleId IdType="pubmed">28183847</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell AP, Guthrie KA, Englund JA, et al. . Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant. Clin Infect Dis 2015; 61:192–202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565994</ArticleId><ArticleId IdType="pubmed">25847977</ArticleId></ArticleIdList></Reference><Reference><Citation>Loria C, Domm JA, Halasa NB, et al. . Human rhinovirus C infections in pediatric hematology and oncology patients. Pediatr Transplant 2015; 19:94–100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4280346</ArticleId><ArticleId IdType="pubmed">25377237</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowrer C, Lee BR, Goyal R, Selvarangan R, Schuster JE.. Outcome of children with rhinovirus detection prior to allogeneic hematopoietic cell transplant. Pediatr Transplant 2018; 22:e13301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167694</ArticleId><ArticleId IdType="pubmed">30338638</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez A, Montoro J, Hernani R, et al. . Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2020; 22:e13301.</Citation><ArticleIdList><ArticleId IdType="pubmed">32363665</ArticleId></ArticleIdList></Reference><Reference><Citation>Waghmare A, Xie H, Kuypers J, et al. . Human rhinovirus infections in hematopoietic cell transplant recipients: risk score for progression to lower respiratory tract infection. Biol Blood Marrow Transplant 2019; 25:1011–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511300</ArticleId><ArticleId IdType="pubmed">30537551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogimi C, Xie H, Leisenring WM, et al. . Initial high viral load is associated with prolonged shedding of human rhinovirus in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2018; 24:2160–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239940</ArticleId><ArticleId IdType="pubmed">30009982</ArticleId></ArticleIdList></Reference><Reference><Citation>Waghmare A, Kuypers JM, Xie H, et al. . Viral load in hematopoietic cell transplant recipients infected with human rhinovirus correlates with burden of symptoms. Biol Blood Marrow Transplant 2015; 21:S317–8.</Citation></Reference><Reference><Citation>Martin EK, Kuypers J, Chu HY, et al. . Molecular epidemiology of human rhinovirus infections in the pediatric emergency department. J Clin Virol 2015; 62:25–31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4403738</ArticleId><ArticleId IdType="pubmed">25542466</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral S, Mamin A, Dantin C, Masouridi-Levrat S, Chalandon Y, Kaiser L, Vu D-L., Rhinovirus infections among hematopoietic stem cell transplant recipients: a pre-transplant dilemma? Viruses 2022; 14:267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8879386</ArticleId><ArticleId IdType="pubmed">35215861</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs SE, Soave R, Shore TB, et al. . Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients. Transpl Infect Dis: Off J Transpl Soc 2013; 15:474–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3962254</ArticleId><ArticleId IdType="pubmed">23890179</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs SE, Soave R, Shore TB, et al. . Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients. Transpl Infect Dis 2013; 15:474–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3962254</ArticleId><ArticleId IdType="pubmed">23890179</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinelli T, Wee LYA, Rowe E, et al. . Respiratory viruses cause late morbidity in recipients of hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2020; 26:782–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31866345</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster JE, Banerjee D, Ahmed I, Selvarangan R.. Frequency of asymptomatic and symptomatic respiratory virus detection in pediatric hematopoietic cell transplant patients. Pediatr Transplant 2020; 24:e13732.</Citation><ArticleIdList><ArticleId IdType="pubmed">32418305</ArticleId></ArticleIdList></Reference><Reference><Citation>Erard V, Chien JW, Kim HW, et al. . Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis 2006; 193:1619–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110078</ArticleId><ArticleId IdType="pubmed">16703503</ArticleId></ArticleIdList></Reference><Reference><Citation>Waghmare A, Xie H, Nguyen T, et al. . Viral quantification of human rhinovirus using digital RT-PCR in lower respiratory tract samples from hematopoietic cell transplant recipients: risk factors determining viral load and association with mortality. Biol Blood Marrow Transplant 2018; 24:S381–2.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>